Back to Rhode Island

S3059 • 2026

AN ACT RELATING TO INSURANCE -- PHARMACY FREEDOM OF CHOICE--FAIR COMPETITION AND PRACTICES (Imposes certain duties, transparency, and accountability from pharmacy benefits managers and pharmacy benefits management services.)

AN ACT RELATING TO INSURANCE -- PHARMACY FREEDOM OF CHOICE--FAIR COMPETITION AND PRACTICES (Imposes certain duties, transparency, and accountability from pharmacy benefits managers and pharmacy benefits management services.)

Passed Legislature

This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.

Sponsor
Britto, Murray, Lawson, Ciccone, Tikoian, LaMountain
Last action
2026-03-26
Official status
Committee recommended measure be held for further study
Effective date
Not listed

Plain English Breakdown

The plain English breakdown is still being put together. The official documents below are already here.

Bill History

  1. 2026-03-26 Committee

    Committee recommended measure be held for further study

  2. 2026-03-20 Rhode Island General Assembly

    Scheduled for hearing and/or consideration (03/26/2026)

  3. 2026-03-12 Rhode Island General Assembly

    Introduced, referred to Senate Health and Human Services

Official Summary Text

AN ACT RELATING TO INSURANCE -- PHARMACY FREEDOM OF CHOICE--FAIR COMPETITION AND PRACTICES (Imposes certain duties, transparency, and accountability from pharmacy benefits managers and pharmacy benefits management services.)

Current Bill Text

Read the full stored bill text
S3059

2026 -- S 3059
========
LC005060
========

STATE OF RHODE ISLAND
IN GENERAL ASSEMBLY
JANUARY SESSION, A.D. 2026
____________
A N A C T
RELATING TO INSURANCE -- PHARMACY FREEDOM OF CHOICE--FAIR
COMPETITION AND PRACTICES

Introduced By:
Senators Britto, Murray, Lawson, Ciccone, Tikoian, and LaMountain

Date Introduced:
March 12, 2026

Referred To:
Senate Health & Human Services
It is enacted by the General Assembly as follows:
1
SECTION 1. Sections 27-29.1-1, 27-29.1-2, 27-29.1-7, 27-29.1-10 and 27-29.1-11 of the
2
General Laws in Chapter 27-29.1 entitled "Pharmacy Freedom of Choice — Fair Competition and
3
Practices" are hereby amended to read as follows:
4

27-29.1-1. Definitions.
5
For purposes of this chapter
, the following terms shall mean
:
6
(1) “Director” shall mean the director of the department of business regulation.
7
(2) “Eligible bidder” shall mean a retail pharmacy, community pharmacy, or pharmacy
8
department registered pursuant to chapter 19.1 of title 5, irrespective of corporate structure or
9
number of locations at which it conducts business, located within the geographical service area of
10
a carrier and willing to bid for participation in a restricted pharmacy network contract.
11
(3) “Insured”
or "covered individual"
shall mean any person who is entitled to have
12
pharmacy services paid by an insurer pursuant to a policy, certificate, contract, or agreement of
13
insurance or coverage.
14
(4) “Insurer” shall mean an insurance carrier as defined in chapters 18, 19, 20, and 41 of
15
this title.
16
(5) “Nonrestricted pharmacy network” shall mean a network that permits any pharmacy to
17
participate on substantially uniform terms and conditions established by an insurer or
pharmacy
18
benefits manager

pharmacy benefit manager
.

1
(6)
“Pharmacy benefits manager”

"Pharmacy benefit manager"
shall
mean any person or
2
entity who or that is not licensed in Rhode Island as an insurer and that develops or manages
3
pharmacy benefits, pharmacy network contracts, or the pharmacy benefit bid process

have the
4
meaning provided in § 27-19-26.2
.
5

(7) “Pharmacy benefit management services” shall mean the management or
6
administration of prescription drug benefits for an insurer, directly or through another entity, and
7
regardless of whether the pharmacy benefit manager and the insurer are related, or associated by
8
ownership, common ownership, organization or otherwise. Such management or administration
9
includes, but is not limited to:
10

(i) The procurement of prescription drugs to be dispensed to patients;
11

(ii) The administration or management of prescription drug benefits;
12

(iii) Operation of a mail service pharmacy;
13

(iv) Claims processing, retail network management, or payment of claims to pharmacies
14
for dispensing prescription drugs;
15

(v) Clinical or other formulary or preferred drug list development or management;
16

(vi) Negotiation or administration of rebates, discounts, payment differentials, or other
17
incentives, for the inclusion of particular prescription drugs in a particular category or to promote
18
the purchase of particular prescription drugs;
19

(vii) Patient compliance, therapeutic intervention, or generic substitution programs;
20

(viii) Disease management;
21

(ix) Drug utilization review or prior authorization;
22

(x) Adjudication of appeals or grievances related to prescription drug coverage;
23

(xi) Contracting with network pharmacies; and
24

(xii) Controlling the cost of covered prescription drugs.
25

(7)
(8)
“Restricted pharmacy network” shall mean an arrangement for the provision of
26
pharmaceutical drug services to insureds that under the terms of an insurer’s policy, certificate,
27
contract, or agreement of insurance or coverage requires an insured or creates a financial incentive
28
for an insured to obtain prescription drug services from one or more participating pharmacies that
29
have entered into a specific contractual relationship with the carrier.
30

(9) "Spread pricing" shall mean the practice of a pharmacy benefit manager retaining an
31
additional amount of money in addition to the amount paid to the pharmacy to fill a prescription.
32

27-29.1-2. Requirement for availability and accessibility of pharmacy services.
33

In accordance with § 23-17.13-3 [repealed], an

An
insurer must demonstrate to the director
34
of health
the willingness and potential ability to ensure that pharmacy services will be provided in

LC005060 - Page 2 of 7
1
a manner to ensure both availability and accessibility of adequate personnel and facilities and in a
2
manner enhancing availability, accessibility, and continuity of service.
3

27-29.1-7. Regulation of pharmacy benefit managers.
4

(a)

Pharmacy benefits managers

Pharmacy benefit manager
shall
be included within the
5
definition of third-party administrator under chapter 20.7 of this title and shall
be regulated
in
6
accordance with chapter 84 of this title

as such
.
The annual report filed by third-party administrators
7
with the department of business regulation shall include: contractual language that provides a
8
complete description of the financial arrangements between the third-party administrator and each
9
of the insurers covering benefit contracts delivered in Rhode Island; and if the third-party
10
administrator is owned by or affiliated with another entity or entities, it shall include an
11
organization chart and brief description that shows the relationships among all affiliates within a
12
holding company or otherwise affiliated. The reporting shall be in a format required by the director
13
and filed with the department as a public record as defined and regulated under chapter 2 of title
14
38.
15

(b) A pharmacy benefit manager shall not substitute or cause the substitution of one
16
prescription drug for another in dispensing a prescription, or alter or cause the altering of the terms
17
of a prescription, except with the approval of the prescriber or as explicitly required or permitted
18
by law, including regulations of the department of business regulation or the department of health.
19
The director is authorized to promulgate rules and regulations to determine when substitution of
20
prescription drugs shall be required or permitted.
21

(c) No pharmacy benefit manager shall, with respect to contracts between such pharmacy
22
benefit manager and a pharmacy or, alternatively, such pharmacy benefit manager and a pharmacy's
23
contracting agent including, but not limited to, a pharmacy services administrative organization:
24

(1) Prohibit or penalize a pharmacist or pharmacy from disclosing to an individual
25
purchasing a prescription medication or service information regarding:
26

(i) The cost of the prescription medication or service to the individual, or the cost of the
27
prescription medication or service to the pharmacy and the pharmacy's reimbursement for that
28
prescription medication or service; or
29

(ii) The availability of any therapeutically equivalent alternative medications or alternative
30
methods of purchasing the prescription medication including, but not limited to, paying a cash
31
price; or
32

(2) Charge or collect from an individual a copayment that exceeds the total submitted
33
charges by the pharmacy for which the pharmacy is paid. If an individual pays a copayment, the
34
pharmacy shall retain the adjudicated costs and the pharmacy benefit manager shall not redact or

LC005060 - Page 3 of 7
1
recoup the adjudicated cost.
2

(d) A pharmacy benefit manager, with respect to contracts between a pharmacy benefit
3
manager and a pharmacy or, alternatively, a pharmacy benefit manager and a pharmacy's
4
contracting agent including, but not limited to a pharmacy services administrative organization,
5
shall include a reasonable process to appeal, investigate and resolve disputes regarding multi-source
6
generic drug pricing. The appeals process shall include the following provisions:
7

(1) The right to appeal by the pharmacy and/or the pharmacy's contracting agent shall be
8
limited to thirty (30) business days following the initial claim submitted for payment;
9

(2) A telephone number through which a network pharmacy may contact the pharmacy
10
benefit manager for the purpose of filing an appeal and an electronic mail address of the individual
11
who is responsible for processing appeals;
12

(3) The pharmacy benefit manager shall send an electronic mail message acknowledging
13
receipt of the appeal. The pharmacy benefit manager shall respond in an electronic message to the
14
pharmacy and/or the pharmacy's contracting agent filing the appeal within seven (7) business days
15
indicating its determination. If the appeal is determined to be valid, the maximum allowable cost
16
for the drug shall be adjusted for the appealing pharmacy effective as of the date of the original
17
claim for payment. The pharmacy benefit manager shall require the appealing pharmacy to reverse
18
and rebill the claim in question in order to obtain the corrected reimbursement;
19

(4) If an update to the maximum allowable cost is warranted, the pharmacy benefit manager
20
or insurer shall adjust the maximum allowable cost of the drug effective for all similarly situated
21
pharmacies in its network in the state on the date the appeal was determined to be valid; and
22

(5) If an appeal is denied, the pharmacy benefit manager shall identify the national drug
23
code of a therapeutically equivalent drug, as determined by the federal Food and Drug
24
Administration, that is available for purchase by pharmacies in this state from wholesalers at a price
25
which is equal to or less than the maximum allowable cost for that drug as determined by the
26
pharmacy benefit manager.
27

27-29.1-10. Costs of enforcement.
28
The total cost of the enforcement
of §§ 27-29.1-3 and 27-29.1-8
shall be borne by the
29
pharmacy benefits manager(s)

pharmacy benefit manager(s)
and/or the insurer(s) against whom the
30
complaint is made on an equal basis and shall include the following expenses:
31
(1) One hundred fifty percent (150%) of the total salaries and benefits paid to the personnel
32
of the department of business regulation engaged in the enforcement less any salary reimbursement;
33
(2) All reasonable technology costs related to the enforcement process. Technology costs
34
shall include the actual cost of software and hardware utilized in the enforcement process and the

LC005060 - Page 4 of 7
1
cost of training personnel in the proper use of the software or hardware;
2
(3) All necessary and reasonable education and training costs incurred by the state to
3
maintain the proficiency and competence of the enforcing personnel. All these costs shall be
4
incurred in accordance with the appropriate state of Rhode Island regulations, guidelines, and
5
procedures
.
; and
6

(4) Any and all surplus funds collected from other enforcement actions from this title levied
7
against pharmacy benefit managers shall be deposited into the health insurance market integrity
8
fund restricted receipt account established pursuant to § 42-157.1-5.
9

27-29.1-11. Evaluation report.
10
The health insurance commissioner, pursuant to § 42-14.5-1, shall evaluate the impact of
11
nonrestricted pharmacy networks

pharmacy benefit manager practices and operations
on health
12
insurance costs in Rhode Island and shall submit a report of findings
to the joint legislative
13
committee on health care oversight on or before May 1, 2005

and recommendations to the general
14
assembly on or before March 31, 2027
.
15
SECTION 2. Chapter 27-29.1 of the General Laws entitled "Pharmacy Freedom of Choice
16
— Fair Competition and Practices" is hereby amended by adding thereto the following section:
17

27-29.1-12. Duty, accountability, and transparency of pharmacy benefit managers.
18

(a)(1) The pharmacy benefit manager shall have a duty and obligation to perform pharmacy
19
benefit management services with care, skill, prudence, diligence, and professionalism.
20

(2) In addition to the duties that the director shall require in regulations promulgated
21
pursuant to subsections (b) and (g) of this section:
22

(i) A pharmacy benefit manager interacting with a covered individual shall have the same
23
duty to a covered individual as the insurer for whom it is performing pharmacy benefit management
24
services; and
25

(ii) A pharmacy benefit manager shall have a duty of good faith and fair dealing with all
26
parties including, but not limited to, covered individuals and pharmacies, with whom it interacts in
27
the performance of pharmacy benefits management services.
28

(b) All funds received by the pharmacy benefit manager in relation to providing pharmacy
29
benefit management services shall be received by the pharmacy benefit manager in trust and shall
30
be used or distributed only pursuant to the pharmacy benefit manager's contract with the insurer or
31
applicable law; including any administrative fee or payment to the pharmacy benefit manager
32
expressly provided for in the contract to compensate the pharmacy benefit manager for its services.
33
Any funds received by the pharmacy benefit manager through spread pricing shall be subject to
34
this section. In addition to any other power conferred by law, the director shall have the authority

LC005060 - Page 5 of 7
1
to promulgate rules and regulations concerning pharmacy benefit manager administrative fees
2
including, but not limited to, limitations on their form and use.
3

(c) The pharmacy benefit manager shall account, annually or more frequently to the insurer
4
for any pricing discounts, rebates of any kind, inflationary payments, credits, clawbacks, fees,
5
grants, chargebacks, reimbursements, or other benefits received by the pharmacy benefit manager.
6
The insurer shall have access to all financial and utilization information of the pharmacy benefit
7
manager in relation to pharmacy benefit management services provided to the insurer.
8

(d) The pharmacy benefit manager shall disclose in writing to the insurer the terms and
9
conditions of any contract or arrangement between the pharmacy benefit manager and any party
10
relating to pharmacy benefit management services provided to the insurer including, but not limited
11
to, dispensing fees paid to the pharmacies.
12

(e) The pharmacy benefit manager shall disclose in writing to the insurer any activity,
13
policy, practice, contract or arrangement of the pharmacy benefit manager that directly or indirectly
14
presents any conflict of interest with the pharmacy benefit manager's relationship with or obligation
15
to the insurer.
16

(f) Any information required to be disclosed by a pharmacy benefit manager to an insurer
17
under this section that is reasonably designated by the pharmacy benefit manager as proprietary or
18
trade secret information shall be kept confidential by the insurer, except as required or permitted
19
by law, including disclosure necessary to prosecute or defend any legitimate legal claim or cause
20
of action. Designation of information as proprietary or trade secret information under this
21
subsection shall have no effect on the obligations of any pharmacy benefit manager or insurer to
22
provide that information to the department of business regulation.
23

(g) The director shall promulgate rules and regulations defining, limiting, and relating to
24
the duties, obligations, requirements and other provisions relating to pharmacy benefit managers
25
under this section.
26
SECTION 3. This act shall take effect upon passage.
========
LC005060
========

LC005060 - Page 6 of 7
EXPLANATION
BY THE LEGISLATIVE COUNCIL
OF
A N A C T
RELATING TO INSURANCE -- PHARMACY FREEDOM OF CHOICE--FAIR
COMPETITION AND PRACTICES
***
1
This act would impose certain duties, transparency, and accountability from pharmacy
2
benefit managers and pharmacy benefit management services.
3
This act would take effect upon passage.
========
LC005060
========

LC005060 - Page 7 of 7